Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

'Disturbing breach' of last resort antibiotics
pig
Unless a globally coordinated approach is taken to combat the issue "MCR-1 is likely to spread to the rest of the world at an alarming rate."
Scientists discover bacteria resistant to polymyxins

Bacteria that is resistant to our last line of antibiotics has been found in widespread samples taken from pigs and humans in southern China, scientists say.

Led by Professor Timothy Walsh from Cardiff University, scientists found a new gene (MCR-1) that allows bacteria to be highly resistant to polymyxins - our last group of antibiotics.

Prof Walsh said the emergence of this gene represents a "disturbing breach" of our last resort drugs "and an end to our last line of defence against infection".

The gene was found on plasmids - mobile DNA that can be copied and transferred easily between different bacterial populations, meaning it has an alarming potential to spread and diversify.

"Our investigations in China found that MCR-1 is already prevalent in E. coli samples found in live animals and meat products, and in a small number of human cases," Prof Walsh said.

Furthermore, there is now evidence to suggest MCR-1-positive E. coli has spread to Laos and Malaysia.

Prof Walsh is best known for his 2011 discovery of the NDM-1 antibiotic resistant superbug in New Delhi's drinking water supply.

Commenting on his latest research, he said: "The rapid spread of similar antibiotic-resistant genes such as NDM-1 suggests that all antibiotics will soon be futile in the face of previously treatable gram-negative bacterial infections such as E. coli and salmonella."

The potential for this to become a global issue will depend on the continued use of polymyxins, such as colistin, in animals, both in China and beyond; the ability of MCR-1 to spread through human strains of E. coli and movements across China's borders.

But unless a globally coordinated approach is taken to combat the issue, Prof Walsh warned "MCR-1 is likely to spread to the rest of the world at an alarming rate."

The full research has been published in The Lancet Infectious Diseases: http://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2815%2900424-7/abstract

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.